Ignite Creation Date:
2024-05-06 @ 8:09 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06270667
Status:
RECRUITING
Last Update Posted:
2024-03-22
First Post:
2024-01-19
Brief Title:
Effects of Exercise Training in Survivors of Lymphoma
Sponsor:
Norwegian School of Sport Sciences
Organization:
Norwegian School of Sport Sciences
Study Overview
Official Title:
The LYMfit Study Exercise Training to Prevent Cardiovascular Disease in Lymphoma Survivors
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LYMfit
Brief Summary:
This study aims to compare the effects of aerobic exercise with or without addition of resistance exercise to usual care in individuals treated with anthracyclines for lymphomas and to compare exercise effects to age- and sex-matched individuals with no prior history of malignant diseases
Detailed Description:
In this study a comparison of the exercise effects between individuals previously treated for specific lymphoma diagnoses and individuals with no history of cancer will be conducted Therefore in addition to a randomized controlled trial in individuals with a previous lymphoma diagnosis ie exercise groups and a non-exercising control group a reference group comprising age- and sex-matched individuals with no history of a cancer diagnosis will also be included Participants in the reference group will undergo the same exercise intervention as the aerobic exercise group This study recruits through invitation only
The primary endpoint in this study is the change in cardiorespiratory fitness assessed as VO2peak Secondary endpoints include common risk factors for cardiovascular disease and cardiometabolic health other variables derived from the cardiopulmonary exercise test and lung function assessments and muscle cellular endpoints from muscle biopsies obtained from m vastus lateralis in addition to patient-reported outcomes
The primary endpoint in this study is the change in cardiorespiratory fitness assessed as VO2peak Secondary endpoints include common risk factors for cardiovascular disease and cardiometabolic health other variables derived from the cardiopulmonary exercise test and lung function assessments and muscle cellular endpoints from muscle biopsies obtained from m vastus lateralis in addition to patient-reported outcomes
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None